{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:55Z","timestamp":1786990315589,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.humimm.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T21:01:21Z","timestamp":1511211681000},"page":"132-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pronase independent flow cytometry crossmatching of rituximab treated patients"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5103-8784","authenticated-orcid":false,"given":"Mats","family":"Alheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wennberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Charlotte","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2017.11.006_b0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-6143.2004.00653.x","article-title":"ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab","volume":"5","author":"Tyden","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2017.11.006_b0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.TP.0000112934.12622.2B","article-title":"Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics","volume":"77","author":"Vieira","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2017.11.006_b0015","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.humimm.2013.08.278","article-title":"Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch","volume":"74","author":"Philippe","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2017.11.006_b0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.humimm.2004.06.001","article-title":"Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab","volume":"65","author":"Bearden","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2017.11.006_b0025","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1111\/tri.12385","article-title":"False-positive CDC x-match after rituximab","volume":"27","author":"Reindl-Schwaighofer","year":"2014","journal-title":"Transpl. Int."},{"key":"10.1016\/j.humimm.2017.11.006_b0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.humimm.2011.01.005","article-title":"Impact of pronase on flow cytometric crossmatch outcome","volume":"72","author":"Hetrick","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2017.11.006_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humimm.2012.07.152","article-title":"False-positive flow cytometry crossmatch results with pronase-treated T-cells in human immunodeficiency virus-infected patients","volume":"73","author":"Sieg","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2017.11.006_b0040","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2017.11.006_b0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.humimm.2016.04.014","article-title":"Flow cytometry crossmatch reactivity with pronase-treated T cells induced by non-HLA autoantibodies in human immunodeficiency virus-infected patients","volume":"77","author":"Szewczyk","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2017.11.006_b0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.transproceed.2011.12.048","article-title":"Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests","volume":"44","author":"Park","year":"2012","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2017.11.006_b0055","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1432-2277.1995.tb01558.x","article-title":"The use of pronase-digested human leukocytes to improve specificity of the flow cytometric crossmatch","volume":"8","author":"Lobo","year":"1995","journal-title":"Transpl. Int."},{"key":"10.1016\/j.humimm.2017.11.006_b0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0041-1345(00)02098-4","article-title":"Pronase improves detection of HLA antibodies in flow crossmatches","volume":"33","author":"Vaidya","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2017.11.006_b0065","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2004-05-1733","article-title":"A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells","volume":"104","author":"Cragg","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2017.11.006_b0070","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1600-6143.2009.02724.x","article-title":"Perception versus reality?: Virtual crossmatch\u2013how to overcome some of the technical and logistic limitations","volume":"9","author":"Tambur","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2017.11.006_b0075","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.transproceed.2004.12.066","article-title":"New crossmatch technique eliminates interference by humanized and chimeric monoclonal antibodies","volume":"37","author":"Book","year":"2005","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2017.11.006_b0080","doi-asserted-by":"crossref","first-page":"587158","DOI":"10.1155\/2015\/587158","article-title":"Solid phase-based cross-matching as solution for kidney allograft recipients pretreated with therapeutic antibodies","volume":"2015","author":"Schlaf","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.humimm.2017.11.006_b0085","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1432-2277.2002.tb00108.x","article-title":"Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation","volume":"15","author":"Lobo","year":"2002","journal-title":"Transpl. Int."},{"key":"10.1016\/j.humimm.2017.11.006_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2017.05.003","article-title":"Depletion of the chimeric drug Rituximab from biological samples","author":"Book","year":"2017","journal-title":"Hum. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917305475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917305475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:50:31Z","timestamp":1759319431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885917305475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0198885917305475"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2017.11.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pronase independent flow cytometry crossmatching of rituximab treated patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}